期刊文献+

胍丁胺抗大鼠身体依赖作用与阿片受体的关系 被引量:6

RELATIONSHIP BETWEEN INHIBITION OF AGMATINE ON RAT MORPHINE PHYSICAL DEPENDENCE AND OPIATE RECEPTORS
下载PDF
导出
摘要 目的··:观察胍丁胺抗大鼠身体依赖作用与阿片受体间的关系。方法··:本文实验采用大鼠身体依赖实验和放射配体结合实验两种方法进行。结果··:胍丁胺虽然能剂量依赖性地抑制纳洛酮催促所引起的吗啡依赖大鼠戒断反应,但对3H-纳洛酮与大鼠前脑阿片受体结合反应无抑制作用(无直接作用),亦不能影响当身体依赖发生时阿片受体对配体的亲和力下降和受体数量下调等代偿性适应变化(无间接作用)。结论··:虽然胍丁胺能抑制阿片类药物身体依赖,但对阿片受体既无直接也无间接作用。 Objective: To observe the relationship between the inhibitory effects of agmatine on rat physical dependence and opioid receptors. Method: The experiments were performed with rat physical dependent test and radiant ligand binding assay. Result: Although agmatine could inhibit the abstinent syndromes of morphine dependent rats precipitated by naloxone in dose-dependent manner, it had neither effect on the binding of 3H-naloxone with opiate receptors in rat forebrain (direct effect) nor influence on the adaptation (indirect effect) characterized by the decrease in affinity of opiate receptors to ligand and down-regulation of receptors which took place in the formative process of physical dependence of opioids. Conclusion: Although agmatine can inhibit rat physical dependence on morphine, it has neither direct nor indirect action on opiate receptors.
出处 《中国药物依赖性杂志》 CAS CSCD 1999年第3期178-181,共4页 Chinese Journal of Drug Dependence
关键词 胍丁胺 吗啡 阿片受体 物质依赖 agmatine morphine opiate receptor substance dependence
  • 相关文献

参考文献3

  • 1Li J,中国药理学报,1999年,20卷
  • 2Li G,Science,1994年,263卷,5149期,966页
  • 3Loh H H,Synapse,1988年,2期,457页

同被引文献46

  • 1杨丽萍,侯炳军,邱学才.中枢5-羟色胺对大鼠吗啡戒断反应的影响[J].中国药物依赖性通报,1996,5(4):216-219. 被引量:7
  • 2Piletz JE,Ivanov TR,Sharp JD,et al.Imidazoline receptor antisera-selected (IRAS) cDNA:cloning and characterization[J].DNA Cell Biol,2000,19(6):319-329.
  • 3Sun Z,Change CH,Ernsberger P.Identification of IRAS/nischarin as an I1-imidazoline receptor in PC12 rat pheochromocytoma cells[J].J Neurochem,2007,101(1):99-108.
  • 4Wang B,Liu Y,Li J,et al.Generation and characterization of novel human IRAS monoclonal antibodies[J].J Biomed Biotechnol,2009,2009:973754-973762.
  • 5Gmveley BR.Alternative splicing:increasing diversity in the proteomic world[J].Trends Genet,2001,17(2):100.
  • 6Modrek B,Lee C.A genomic view of alternative splicing[J].Nat Genet,2002,30(1):13.
  • 7Caceres JF,Komblihtt AR.Alternative splicing:multiple control mechanisms and involvement in human disease[J].Trends Genet,2002,18(4):186.
  • 8Mironov AA,Kichett JW,Gelfand MS.Frequent alternative splicing of human genes[J].Genome Res,1999,9(12):1288.
  • 9Dehay C,Kennedy H.Transcriptional regulation and alternative splicing make for better brains[J].Neuron,2009,62(4):455-457.
  • 10Pio R,Montuenga LM.Alternative splicing in lung cancer[J].Thorac Oncol,2009,4(6):674-678.

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部